{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:10Z","timestamp":1783347850963,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"START-Program of the Faculty of Medicine of the RWTH Aachen University, Aachen, Germany.","award":["(#01\/23)"],"award-info":[{"award-number":["(#01\/23)"]}]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal liver metastases (CRLM) are the main determinant of survival in colorectal cancer, and radical resection offers the best oncological outcomes. However, heterogeneous clinicopathological features make appropriate patient selection essential. Numerous clinical risk scores (CRS) have been proposed to predict outcomes after liver resection for CRLM. This study evaluated the prognostic performance of 11 established CRS regarding survival after curative-intent resection of CRLM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included patients who underwent curative-intent liver resection for CRLM at University Hospital RWTH Aachen, Germany, between 2010 and 2021. The following CRS were analyzed: Fong, Nordlinger, Nagashima, Konopke, Basingstoke Predictive Index, Tumor Burden Score, Resection Severity Index, Kulik, RAS-mutation CRS, Comprehensive Evaluation of Relapse Risk (CERR) score, and the Genetic and Morphological Evaluation score. Overall survival (OS) was compared using Kaplan\u2013Meier analysis and log-rank testing. Predictive accuracy was assessed using the Akaike information criterion, Harrell\u2019s C-index for OS, and area under the curve (AUC) analyses for 1- and 5-year survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 528 patients were included, with a median OS of 26 months (95% confidence interval [CI] 23\u201328). All CRS except the Resection Severity Index significantly stratified patients according to OS. CERR consistently ranked among the top three scores for both the Akaike information criterion (1725) and the C-index (0.61) and had the highest accuracy for predicting 1-year survival (AUC 0.654,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.001) and 5-year survival (AUC 0.62,\n                      <jats:italic>p\u2009<\/jats:italic>\n                      &lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although the CERR demonstrated the most consistent predictive performance, 10 of 11 evaluated CRS effectively stratified patients according to long-term survival after CRLM resection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19627-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:28:57Z","timestamp":1777321737000},"page":"7046-7056","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comparison of 11 Clinical Risk Scores for Prediction of Survival After Curative-Intent Resection of Colorectal Liver Metastases"],"prefix":"10.1245","volume":"33","author":[{"given":"Felix","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska A.","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Hitpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa H.","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven A.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Oldhafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Beetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"von Websky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian W. R.","family":"Vondran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Joechle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5138-4214","authenticated-orcid":false,"given":"Iakovos","family":"Amygdalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"2","key":"19627_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","volume":"244","author":"S Manfredi","year":"2006","unstructured":"Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254\u20139.","journal-title":"Ann Surg."},{"issue":"1","key":"19627_CR2","doi-asserted-by":"publisher","first-page":"10594","DOI":"10.1038\/s41598-024-61386-8","volume":"14","author":"S Elmaagacli","year":"2024","unstructured":"Elmaagacli S, Thiele C, Meister F, et al. Preoperative three-dimensional lung volumetry predicts respiratory complications in patients undergoing major liver resection for colorectal metastases. Sci Rep. 2024;14(1):10594.","journal-title":"Sci Rep."},{"issue":"11","key":"19627_CR3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.hpb.2023.06.016","volume":"25","author":"K Joechle","year":"2023","unstructured":"Joechle K, Amygdalos I, Schmidt F, et al. Value of prognostic scoring systems in the era of multimodal therapy for recurrent colorectal liver metastases. HPB (Oxford). 2023;25(11):1354\u201363.","journal-title":"HPB (Oxford)."},{"issue":"1","key":"19627_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00423-023-03082-1","volume":"408","author":"I Amygdalos","year":"2023","unstructured":"Amygdalos I, Hitpass L, Schmidt F, et al. Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases. Langenbecks Arch Surg. 2023;408(1):343.","journal-title":"Langenbecks Arch Surg."},{"key":"19627_CR5","doi-asserted-by":"crossref","unstructured":"Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Fran\u00e7aise de Chirurgie. Cancer. 1996;77(7):1254-1262.","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I"},{"key":"19627_CR6","doi-asserted-by":"crossref","unstructured":"Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309-18; discussion 318-21.","DOI":"10.1097\/00000658-199909000-00004"},{"issue":"2","key":"19627_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/archsurg.140.2.183","volume":"140","author":"M Schindl","year":"2005","unstructured":"Schindl M, Wigmore SJ, Curie EJ, et al. Prognostic scoring in colorectal cancer liver metastases: development and Validation. Arch Surg. 2005;140(2):183\u20139.","journal-title":"Arch Surg."},{"issue":"1","key":"19627_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1478-3231.2008.01845.x","volume":"29","author":"R Konopke","year":"2009","unstructured":"Konopke R, Kersting S, Distler M, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int. 2009;29(1):89\u2013102.","journal-title":"Liver Int."},{"issue":"1","key":"19627_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","volume":"247","author":"M Rees","year":"2008","unstructured":"Rees M, Tekkis PP, Welsh FKS, et al. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247(1):125\u201335.","journal-title":"Ann Surg."},{"issue":"1","key":"19627_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/SLA.0000000000002064","volume":"267","author":"K Sasaki","year":"2018","unstructured":"Sasaki K, Morioka D, Conci S, et al. The tumor burden score: a new, \u201cmetro-ticket\u201d prognostic tool for colorectal liver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132\u201341.","journal-title":"Ann Surg."},{"issue":"1","key":"19627_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/SLA.0000000000002319","volume":"269","author":"KW Brudvik","year":"2019","unstructured":"Brudvik KW, Jones RP, Giuliante F, et al. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019;269(1):120\u20136.","journal-title":"Ann Surg."},{"issue":"9","key":"19627_CR12","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/bjs.10838","volume":"105","author":"GA Margonis","year":"2018","unstructured":"Margonis GA, Sasaki K, Gholami S, et al. Genetic and morphological evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105(9):1210\u201320.","journal-title":"Br J Surg."},{"issue":"7","key":"19627_CR13","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1634\/theoncologist.2019-0797","volume":"25","author":"Y Chen","year":"2020","unstructured":"Chen Y, Chang W, Ren L, et al. Comprehensive evaluation of relapse risk (CERR) score for colorectal liver metastases: development and validation. Oncologist. 2020;25(7):e1031\u201341.","journal-title":"Oncologist."},{"issue":"5","key":"19627_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jso.21346","volume":"100","author":"S Merkel","year":"2009","unstructured":"Merkel S, Bialecki D, Meyer T, et al. Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J Surg Oncol. 2009;100(5):349\u201357.","journal-title":"J Surg Oncol."},{"issue":"12","key":"19627_CR15","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1245\/s10434-009-0654-7","volume":"16","author":"C Reissfelder","year":"2009","unstructured":"Reissfelder C, Rahbari NN, Koch M, et al. Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol. 2009;16(12):3279\u201388.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"19627_CR16","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/cancers14102356","volume":"14","author":"K Bolhuis","year":"2022","unstructured":"Bolhuis K, Wensink GE, Elferink MAG, et al. External validation of two established clinical risk scores predicting outcome after local treatment of colorectal liver metastases in a nationwide cohort. Cancers (Basel). 2022;14(10):2356.","journal-title":"Cancers (Basel)."},{"issue":"2","key":"19627_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00534-002-0778-7","volume":"11","author":"I Nagashima","year":"2004","unstructured":"Nagashima I, Takada T, Matsuda K, et al. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg. 2004;11(2):79\u201383.","journal-title":"J Hepatobiliary Pancreat Surg."},{"issue":"4","key":"19627_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.suronc.2017.08.002","volume":"26","author":"J Gwiasda","year":"2017","unstructured":"Gwiasda J, Schrem H, Kaltenborn A, et al. Introduction of the resection severity index as independent risk factor limiting survival after resection of colorectal liver metastases. Surg Oncol. 2017;26(4):382\u20138.","journal-title":"Surg Oncol."},{"key":"19627_CR19","doi-asserted-by":"publisher","first-page":"5618581","DOI":"10.1155\/2018\/5618581","volume":"2018","author":"U Kulik","year":"2018","unstructured":"Kulik U, Plohmann-Meyer M, Gwiasda J, et al. Proposal of two prognostic models for the prediction of 10-year survival after liver resection for colorectal metastases. HPB Surg. 2018;2018:5618581.","journal-title":"HPB Surg."},{"issue":"3","key":"19627_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1072-7515(99)00089-7","volume":"189","author":"S Iwatsuki","year":"1999","unstructured":"Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999;189(3):291\u20139.","journal-title":"J Am Coll Surg."},{"issue":"3","key":"19627_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1602\/neurorx.1.3.323","volume":"1","author":"A Feigin","year":"2004","unstructured":"Feigin A. Evidence from biomarkers and surrogate endpoints. NeuroRX. 2004;1(3):323\u201330.","journal-title":"NeuroRX."},{"key":"19627_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716\u201323.","journal-title":"IEEE Trans Automat Contr."},{"issue":"18","key":"19627_CR23","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr","year":"1982","unstructured":"Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543\u20136.","journal-title":"JAMA."},{"key":"19627_CR24","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ."},{"issue":"5","key":"19627_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s11605-019-04299-6","volume":"24","author":"K Joechle","year":"2020","unstructured":"Joechle K, Vreeland TJ, Vega EA, et al. Anatomic resection is not required for colorectal liver metastases with RAS mutation. J Gastrointest Surg. 2020;24(5):1033\u20139.","journal-title":"J Gastrointest Surg."},{"issue":"1","key":"19627_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00268-007-9285-y","volume":"32","author":"M Arru","year":"2008","unstructured":"Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008;32(1):93\u2013103.","journal-title":"World J Surg."},{"issue":"6","key":"19627_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000479850","volume":"33","author":"HJ Schlitt","year":"2017","unstructured":"Schlitt HJ, Hackl C, Lang SA. \u201cIn-situ split\u201d liver resection\/ALPPS - historical development and current practice. Visc Med. 2017;33(6):408\u201312.","journal-title":"Visc Med."},{"issue":"10","key":"19627_CR28","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1245\/s10434-011-1819-8","volume":"18","author":"N Ayez","year":"2011","unstructured":"Ayez N, Lalmahomed ZS, van der Pool AEM, et al. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol. 2011;18(10):2757\u201363.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"19627_CR29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archsurg.139.12.1326","volume":"139","author":"SR Grobmyer","year":"2004","unstructured":"Grobmyer SR, Fong Y, D\u2019Angelica M, et al. Diagnostic laparoscopy prior to planned hepatic resection for colorectal metastases. Arch Surg. 2004;139(12):1326\u201330.","journal-title":"Arch Surg."},{"issue":"94\u201395","key":"19627_CR30","first-page":"1452","volume":"56","author":"A Ivanecz","year":"2009","unstructured":"Ivanecz A, Potrc S, Horvat M, et al. The validity of clinical risk score for patients undergoing liver resection for colorectal metastases. Hepatogastroenterology. 2009;56(94\u201395):1452\u20138.","journal-title":"Hepatogastroenterology."},{"issue":"6","key":"19627_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ejso.2013.02.024","volume":"39","author":"L Spelt","year":"2013","unstructured":"Spelt L, Nilsson J, Andersson R, et al. Artificial neural networks \u2013 A method for prediction of survival following liver resection for colorectal cancer metastases. Eur J Surg Oncol. 2013;39(6):648\u201354.","journal-title":"Eur J Surg Oncol."},{"issue":"13","key":"19627_CR32","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1245\/s10434-020-08991-9","volume":"27","author":"AZ Paredes","year":"2020","unstructured":"Paredes AZ, Hyer JM, Tsilimigras DI, et al. A novel machine-learning approach to predict recurrence after resection of colorectal liver metastases. Ann Surg Oncol. 2020;27(13):5139\u201347.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"19627_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.21037\/hbsn-21-453","volume":"12","author":"CSN Lam","year":"2022","unstructured":"Lam CSN, Bharwani AA, Chan EHY, et al. A machine learning model for colorectal liver metastasis post-hepatectomy prognostications. Hepatobiliary Surg Nutr. 2022;12(4):495\u2013506.","journal-title":"Hepatobiliary Surg Nutr."},{"key":"19627_CR34","doi-asserted-by":"crossref","unstructured":"Amygdalos I, Muller-Franzes G, Bednarsch, et al. Novel Machine Learning Algorithm Can Stratify Risk of Poor Overall Survival after Curative Resection of Colorectal Liver Metastases. HPB. 2023;25 Suppl 2:S302-S303.","DOI":"10.1016\/j.hpb.2023.07.211"},{"issue":"4","key":"19627_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.21037\/hbsn-24-187","volume":"13","author":"I Amygdalos","year":"2024","unstructured":"Amygdalos I, Truhn D, Vondran FWR. Outcome prediction after resection of colorectal cancer liver metastases: out with the old, in with the new? Hepatobiliary Surg Nutr. 2024;13(4):732\u20135.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"6","key":"19627_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/bjs.10834","volume":"105","author":"S Yamashita","year":"2018","unstructured":"Yamashita S, Chun YS, Kopetz SE, et al. Biomarkers in colorectal liver metastases. Br J Surg. 2018;105(6):618\u201327.","journal-title":"Br J Surg."},{"issue":"5","key":"19627_CR37","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1158\/1078-0432.CCR-19-2390","volume":"26","author":"J Datta","year":"2020","unstructured":"Datta J, Smith JJ, Chatila WK, et al. Coaltered Ras\/B-raf and TP53 is associated with extremes of survivorship and distinct patterns of metastasis in patients with metastatic colorectal cancer. Clin Cancer Res. 2020;26(5):1077\u201385.","journal-title":"Clin Cancer Res."},{"issue":"5","key":"19627_CR38","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/SLA.0000000000003527","volume":"270","author":"H Lang","year":"2019","unstructured":"Lang H, Baumgart J, Heinrich S, et al. Extended molecular profiling improves stratification and prediction of survival after resection of colorectal liver metastases. Ann Surg. 2019;270(5):799\u2013805.","journal-title":"Ann Surg."},{"issue":"8","key":"19627_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.5306\/wjco.v12.i8.623","volume":"12","author":"SA Lang","year":"2021","unstructured":"Lang SA, Bednarsch J, Czigany Z, et al. Liver transplantation in malignant disease. World J Clin Oncol. 2021;12(8):623\u201345.","journal-title":"World J Clin Oncol."},{"key":"19627_CR40","doi-asserted-by":"publisher","unstructured":"Lokancevic T, Keil S, Bruners P, et al. Treatment of Irresectable Colorectal Liver Metastases by Combination of Liver Resection and Percutaneous Tumor Ablation: Mid-term Outcome. Rofo. Online ahead of print 2026 Feb 6. https:\/\/doi.org\/10.1055\/a-2781-8926.","DOI":"10.1055\/a-2781-8926"},{"issue":"3","key":"19627_CR41","doi-asserted-by":"publisher","first-page":"411","DOI":"10.21037\/hbsn-24-121","volume":"14","author":"G Josephs","year":"2025","unstructured":"Josephs G, Hitpass L, Truhn D, et al. Splenic hypertrophy predicts liver-specific complications in patients undergoing major liver resection for colorectal liver metastases, after preoperative chemotherapy. Hepatobiliary Surg Nutr. 2025;14(3):411\u201322.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"10","key":"19627_CR42","doi-asserted-by":"publisher","first-page":"e70324","DOI":"10.1111\/liv.70324","volume":"45","author":"R Siepmann","year":"2025","unstructured":"Siepmann R, Schneider CV, von der Stueck MS, et al. The impact of access to clinical guidelines on LLM-based treatment recommendations for chronic hepatitis B. Liver Int. 2025;45(10):e70324.","journal-title":"Liver Int."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19627-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19627-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:41:19Z","timestamp":1783345279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19627-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["19627"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19627-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The study was conducted under the ethical approval of the institutional review board of the RWTH Aachen University (EK-001\/21) and in accordance with the current version of the Declaration of Helsinki, the Declaration of Istanbul, and good clinical practice guidelines. The need for informed consent was waived because of the retrospective study design and collection of readily available clinical data. The authors are accountable for all aspects of the work (if applied, including full data access, integrity of the data, and the accuracy of the data analysis) and for ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}